Protection from Procedural Myocardial Injury by Omega-3 Polyunsaturated Fatty Acids (PUFAs): Is Related with Lower Levels of Creatine Kinase-MB (CK-MB) and Troponin I?

Reduced Thrombin Formation and Altered Fibrin Clot Properties Induced by Polyunsaturated Omega-3 Fatty Acids on Top of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (OMEGA-PCI Clot)

(2011) Grzegorz Gajos et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: A meta-analysis

(2011) Dmitriy N. Feldman et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents

(2010) Yee W Wong et al.   CURRENT OPINION IN CARDIOLOGY

Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

(2010) Grzegorz Gajos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Relation of Troponin I Levels Following Nonemergent Percutaneous Coronary Intervention to Short- and Long-Term Outcomes

(2009) Dmitriy N. Feldman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Increasing intakes of the long-chain ω-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men

(2009) Nicolas Guillot et al.   FASEB JOURNAL

Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

(2009) Abhiram Prasad et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention

(2008) Abhiram Prasad et al.   Circulation-Cardiovascular Interventions